FutureChem

5 clinical trials · Sponsor

Record	Firm	Date
[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer (NCT05936658)	FutureChem	2023-05-08
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2 (NCT05579184)	FutureChem	2022-10-30
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application (NCT05458544)	FutureChem	2022-09-01
Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis (NCT05004285)	FutureChem	2021-04-28
[177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer. (NCT04509557)	FutureChem	2020-10-14

Every clearance here is in the API, with alerts when new ones post.